Quotient Sciences to recapitalise with global private equity firm Permira
New investment provides substantial new funding to fuel the next stage of Quotient’s growth.
List view / Grid view
New investment provides substantial new funding to fuel the next stage of Quotient’s growth.
The price of over 3400 drugs have been hiked in the first half of 2019, surpassing the number of hikes imposed during the same period last year.
Pharmaceutical company, Pfizer, has announced it has completed the acquisition of Therachon for $340 million.
AbbVie Inc. and Allergan plc have entered into a definitive transaction agreement under which AbbVie will acquire Allergan.
A pharmaceutical company and a local council have announced investments to improve paediatric medicines manufacturing.
DHL Supply Chain is investing millions of dollars to expand its pharmaceutical and medical device distribution network in the US.
The UK’s newest life sciences asset, Health Innovation Research Alliance Northern Ireland (HIRANI), has been launched at a BIO reception.
The global pharmaceutical intermediates market is likely to see year-on-year growth in 2019, by an estimated 3.6 percent rate.
New briefing documents provide policy recommendations to help the EU tackle high medicines prices brought about by market monopolies.
Member countries of WHO have agreed to support pricing transparency for medicines, vaccines and other health products.
Global active pharmaceutical ingredients market set to surpass US$274.9 billion by 2026.
Pharmaceutical manufacturers and wholesale distributors could start losing billions of dollars because of faulty barcode scans.
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded TB Alliance a CETR grant for tuberculosis drug development.
A $100 million investment has been made to support long-term vaccine manufacturing capabilities in the US.
UK-based biotech companies raised £2.2billion from investors in 2018, an increase of 85 percent from the year before, a report has found...